“Cialis Challenge”: ED Drug Sampling Hides True Market Growth, Icos Says

Increased prescription sampling within the erectile dysfunction market has caused an understatement of the category's overall growth, Icos VP-Sales & Marketing Leonard Blum told investors May 3